今天和大家分享的是2020年11月2日发表于《CELL DEATH AND DIFFERENTIATION》上题为“KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway”的...
Lung cancerIn addition to the role of programmed cell death ligand 1 (PD-L1) in facilitating tumour cells escape from immune surveillance, it is considered as a crucial effector in transducing intrinsic signals to promote tumour development. Our previous study has pointed out that PD-L1 promotes...
KP-4 Cell:人胰腺导管细胞癌细胞系 H341细胞系相关产品:MTEC1细胞、Radiation Effects Research Foundation-Lung Cancer-MS细胞、MDAMB435细胞 Hs 832(C).T细胞系相关产品:H-2085细胞、NW38细胞、HCC-202细胞 T-47-D细胞系相关产品:BTI-TN5B1-4细胞、Panc_08_13细胞、KMST6细胞 ...
PG [Human lung carcinoma]细胞类似产品::NCIH2009细胞、LWnt3A细胞、CL11细胞 MDA-MB361细胞类似产品::DMS-53细胞、LA4细胞、Mouse Podocyte Clone-5细胞 Hx-147细胞类似产品::PLB 985细胞、MES-23.5细胞、PG-4细胞 SUDHL-4细胞类似产品::NCI H345细胞、NW-MEL-38细胞、H-676B细胞 ...
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway. Cell Death Differ. 2021;28(4):1284–300. Article PubMed CAS Google Scholar Sheng C, Qiu J, He Z, Wang H, Wang Q, Guo Z, et al. Suppression of...
[1].Bacac M, Stamenkovic I. Metastatic cancer cell. Annu Rev Pathol. 2008;3:221-47. doi: 10.1146/annurev.pathmechdis.3.121806.151523. PMID: 18233952. [2]NCCN非小细胞肺癌临床实践指南2022.V4 [3]Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals...
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway. Cell Death Differ. 2021;28:1284–300. Article CAS PubMed Google Scholar Yang F, Li L, Mu Z, Liu P, Wang Y, Zhang Y, et al. Tumor-promoting ...
Lung Cancer Volume 8, Issue 2, July 1992, Pages 131 About ScienceDirect Contact and support Terms and conditions Privacy policy Copyright © 2015 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V. Cookies are used by this sit...
The medical treatment does this with the help of a photosensitizing drug and a light source that activates the applied drug, destroying cancer cells. PDT is approved to treat non-small cell lung cancer, esophageal cancer, and Barrett's esophagus. It treats actinic keratosis, as well as acne,...
[4]David R. Spigel, Corinne Faivre-Finn, Jhanelle E. Gray, et al: Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer. DOI https://doi.org/10.1200/JCO.21.01308....